Latest news
Loading news…
Primo Thera
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Seoul, Seoul-t'ukpyolsi, South Korea Founded 2022 For Profit
Primo Thera is developing small-molecule new drugs based on the demand for new mechanisms and oral autoimmune disease treatments.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
1
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 9
- Patents granted
- 1
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 2022
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 1
- HQ
- Seoul, Seoul-t'ukpyolsi, South Korea
- Region
- Asia-Pacific (APAC)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- 4.8
- Trend (90d)
- 6
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Primo Thera
Loading news…
FAQs about Primo Thera
People who checked this page also checked these
Browse the full Acquirezy directory.